Monday, 21 May 2018
Latest news
Main » AbbVie Inc (ABBV) Shares Sold by JNBA Financial Advisors

AbbVie Inc (ABBV) Shares Sold by JNBA Financial Advisors

12 February 2018

The stock increased 0.38% or $0.13 during the last trading session, reaching $33.99. About 1.56M shares traded or 59.04% up from the average. T-Mobile US, Inc. (NYSE:TMUS) has risen 62.63% since February 11, 2017 and is uptrending. It has outperformed by 87.39% the S&P500.

Prudential Financial Inc decreased its stake in Abbvie Inc (ABBV) by 1.99% based on its latest 2017Q3 regulatory filing with the SEC. Richmond Hill Investment Company sold 39,289 shares as the company's stock declined 1.97% while stock markets rallied. The Uss Investment Management Ltd holds 96,600 shares with $7.32 million value, up from 86,100 last quarter. Smith Salley & Associates who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $177.68B market cap company. Spectrum Management Group Inc. now owns 28,100 shares of the company's stock worth $2,038,000 after purchasing an additional 2,892 shares during the last quarter. The shares were sold at an average price of $98.45, for a total value of $8,569,088.00. Altria Group, Inc. (NYSE:MO) has risen 11.92% since February 10, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

More news: Australian sites among thousands hacked to include mining script

Prudential Financial Inc, which manages about $60.47B US Long portfolio, upped its stake in Builders Firstsource Inc (NASDAQ:BLDR) by 317,380 shares to 328,870 shares, valued at $5.92 million in 2017Q3, according to the filing. It also increased its holding in Integra Lifesciences Hldgs C (NASDAQ:IART) by 664,000 shares in the quarter, for a total of 1.09 million shares, and has risen its stake in Regeneron Pharmaceuticals (NASDAQ:REGN).

Since October 10, 2017, it had 0 insider purchases, and 4 insider sales for $8.29 million activity. $1.66 million worth of AbbVie Inc. Shares for $231,206 were sold by Majoras Deborah P on Tuesday, August 15. Also, Chairman Richard A. Gonzalez sold 218,193 shares of the business's stock in a transaction on Tuesday, November 21st.

More news: 'We are at WAR' Turkish helicopter SHOT DOWN in Syria killing soldiers

Investors sentiment decreased to 1 in 2017 Q3. The New York-based Eagle Capital Management Llc has invested 2.97% in the stock. 142 funds opened positions while 524 raised stakes. Ngam LP has 0.25% invested in AbbVie Inc. Millennium Mngmt Ltd Llc reported 497,085 shares. The South Carolina-based Ccm Inv Advisers Lc has invested 2.37% in Visa Inc. Hamlin Capital Mgmt Ltd Liability accumulated 802,215 shares. Mcf Limited accumulated 0.06% or 1,121 shares. State Of Alaska Department Of Revenue invested in 0.89% or 275,761 shares. Following the sale, the senior vice president now directly owns 113,118 shares in the company, valued at $11,136,467.10. 525.28 million shares or 0.91% more from 520.53 million shares in 2017Q2 were reported. New England Research And Mgmt Incorporated holds 0.61% or 9,308 shares in its portfolio. Cambridge Invest Rech reported 0% stake. Its down 0.15, from 1 in 2017Q2. Bancorporation Of America Corp De reported 0.14% stake. Fincl Advantage Incorporated reported 0.03% in Altria Group, Inc. (NYSE:V), 34 have Buy rating, 0 Sell and 8 Hold. Therefore 29% are positive. Visa Inc. had 125 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of AbbVie Inc. Finally, Hershey Trust Co. bought a new position in AbbVie during the 3rd quarter worth approximately $139,000. Out of 4 Wall Street analysts rating DISH Network, 2 give it "Buy", 1 "Sell" rating, while 1 recommend "Hold". Zacks Investment Research raised AbbVie from a "hold" rating to a "buy" rating and set a $102.00 price target on the stock in a research report on Tuesday, October 17th. BidaskClub upgraded AbbVie from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, September 6th. Jefferies has "Buy" rating and $18.0 target. The firm earned "Underperform" rating on Monday, November 16 by Credit Agricole. The company was upgraded on Friday, March 3 by Jefferies. The stock presently has a consensus rating of "Buy" and an average target price of $117.26. The stock has "Buy" rating by Piper Jaffray on Thursday, February 1. Seven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Therefore 72% are positive. Jefferies maintained the stock with "Hold" rating in Friday, November 17 report. The firm has " rating given on Monday, September 28 by Citigroup. The firm has "Neutral" rating given on Friday, December 18 by Atlantic Securities. (NYSE:ABBV) were released by: Investorplace.com and their article: "Don't Chase AbbVie Inc Stock After Its Huge Earnings Win" published on January 26, 2018 as well as Seekingalpha.com's news article titled: "Don't Miss Out, Act Now On AbbVie" with publication date: February 05, 2018. (NYSE:ABBV) on Tuesday, February 23 to "Buy" rating. The rating was maintained by UBS on Friday, October 23 with "Buy". The stock has "Neutral" rating by Goldman Sachs on Thursday, July 14. The rating was initiated by Leerink Swann on Tuesday, October 18 with "Mkt Perform". The rating was downgraded by UBS to "Neutral" on Monday, September 25.

Investors sentiment decreased to 0.85 in Q3 2017. It fall, as 50 investors sold BA shares while 609 reduced holdings. 76 funds opened positions while 330 raised stakes. 4,420 were reported by Ipswich Investment Mngmt Com. Daiwa Secs Grp Inc owns 14,900 shares.

More news: South Korea's chief invited to North Korea

Altalis Capital Management Llc holds 8.15% of its portfolio in DISH Network Corporation for 229,059 shares. Advent Cap Management De holds 0.01% in AbbVie Inc. (NYSE:ABBV) for 1.38 million shares. (NYSE:MO). Beacon Advsrs holds 1.73% or 2,291 shares in its portfolio. Moreover, Tourbillon Capital Partners L.P. has 4.94% invested in the company for 3.76 million shares. Woodstock reported 1.58% of its portfolio in AbbVie Inc. Also, insider Laura J. Schumacher sold 145,510 shares of AbbVie stock in a transaction on Friday, December 15th. Patten And Patten Tn, a Tennessee-based fund reported 188,180 shares. Fiera Capital accumulated 277,571 shares.